ArticleScientific reports2025
Benzydamine rescues ethanol-induced teratogenesis in zebrafish FASD model.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prenatal Benzydamine Exposure Induces Fetal Growth Restriction and Maternal Oxidative Stress in Rats.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fetal alcohol spectrum disorders (FASD) are a group of physical, behavioral, and cognitive impairments caused by ethanol exposure during pregnancy. Zebrafish have emerged as a useful model for researching FASD and its variants in recent years. Oxidative stress has been identified as the primary damaging pathway, notwithstanding the possibility of other mechanisms at play. In this regard it's important to put an effort towards antioxidants which can exhibits and bare a potential to counteract the oxidative stress induced by ethanol during embryos development. Previosuly benzydamine has shown to protect macrophages against ethanol-induced condition by stabilizing redox homeostatis. This study aims to repurpose the Non-Steroidal Anti-Inflammatory Drug (NSAID) benzydamine to mitigate ethanol-induced teratogenesis during the early embryonic stage in Zebrafish. Zebrafish embryos were treated with 1% ethanol at 2 h post fertilization (hpf) and co-exposed with benzydamine (5-20 µM) after 2 h of ethanol treatment for 24 h. Reactive oxygen Species (ROS) and biochemical analysis was carried out at 48hpf. 1% ethanol significantly increased the production of ROS along with increased in lipid peroxidation followed by a decrease in glutathione (GSH) level when compoared to the control group (P < 0.001). These conditions were positively encountered by benzydamine (10, 15 µM) and returned to basal level. Involvement of two ethanol metabolizing enzymes cyp2y3 (Cytochrome P450, family 2, subfamily Y, polypeptide 3) and cyp3a65 Cytochrome P450, family 3, subfamily A, polypeptide 65 ) were also studied at 48hpf. 1% ethanol exposure aggregately elevated the expression of these two enzymes which showed a significant decrease in the benzydamine treated groups. Furthermore, the malformations and cellular damage due to 1% ethanol was studied at 96hpf, where 1% ethanol made severe malformation along with muscle fiber alteration, apoptosis in the brain and eye as manifested. These conditions were successfully reverted by benzydamine. In conclusion, ethanol causes oxidative stress, cellular damage along with severe malformation at early embryonic stage, which were partially prevented by the exposure of benzydamine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.